Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun;3(2):68-76.
doi: 10.1007/s40778-017-0079-3. Epub 2017 Apr 12.

Bioartificial Kidneys

Affiliations

Bioartificial Kidneys

Peter R Corridon et al. Curr Stem Cell Rep. 2017 Jun.

Abstract

Purpose of review: Historically, there have been many advances in the ways in which we treat kidney diseases. In particular, hemodialysis has set the standard for treatment since the early 1960s and continues today as the most common form of treatment for acute, chronic, and end-stage conditions. However, the rising global prevalence of kidney diseases and our limited understanding of their etiologies have placed significant burdens on current clinical management regimens. This has resulted in a desperate need to improve the ways in which we treat the underlying and ensuing causes of kidney diseases for those who are unable to receive transplants.

Recent findings: One way of possibly addressing these issues is through the use of improved bioartificial kidneys. Bioartificial kidneys provide an extension to conventional artificial kidneys and dialysis systems, by incorporating aspects of living cellular and tissue function, in an attempt to better mimic normal kidneys. Recent advancements in genomic, cellular, and tissue engineering technologies are facilitating the improved design of these systems.

Summary: In this review, we outline various research efforts that have focused on the development of regenerated organs, implantable constructs, and whole bioengineered kidneys, as well as the transitions from conventional dialysis to these novel alternatives. As a result, we envision that these pioneering efforts can one day produce bioartificial renal technologies that can either perform or reintroduce essential function, and thus provide practical options to treat and potentially prevent kidney diseases.

Keywords: Bioengineering; Bioratificial kidney; Cell therapy and gene therapy; Dialysis; Regenerative medicine.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Peter R. Corridon has a patent pending on hydrodynamic methods for delivering fluids to kidney tissues and related materials and methods. In Kap Ko, James J. Yoo, and Anthony Atala declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
An illustration of bioactive compound, gene therapy, and cell therapy-based renal regeneration technologies. PDGF platelet-derived growth factor, TGF-β transforming growth factor-beta, VEGF vascular endothelial growth factor
Fig. 2
Fig. 2
An outline of the properties of scaffolding systems and the applications for treatment of renal diseases

Similar articles

Cited by

References

    1. Stevens LA, Viswanathan G, Weiner DE. CKD and ESRD in the elderly: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis. 2010;17(4):293–301. - PMC - PubMed
    1. Ojo A. Addressing the global burden of chronic kidney disease through clinical and translational research. Trans Am Clin Climatol Assoc. 2014;125:229–46. - PMC - PubMed
    1. Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med. 2013;369(14):1336–43. - PubMed
    1. Global Facts: About Kidney Disease [Internet]. The National Kidney Foundation. 2015 2016. Available from: https://www.kidney.org/kidneydisease/global-facts-about-kidney-disease.
    1. Kidney Disease Statistics for the United States [Internet]. 2016. Available from: https://www.niddk.nih.gov/health-information/health-statistics/Pages/kid....

LinkOut - more resources